Della Puppa Alessandro, d'Avella Elena, Rossetto Marta, Volpin Francesco, Rustemi Oriela, Gioffrè Giorgio, Lombardi Giuseppe, Rolma Giuseppe, Scienza Renato
Department of Neurosurgery, Padua University Hospital, Padua, Italy.
Department of Neurosurgery, Padua University Hospital, Padua, Italy.
World Neurosurg. 2015 Sep;84(3):741-50. doi: 10.1016/j.wneu.2015.04.055. Epub 2015 May 7.
Despite technical surgical advance, the ultimate management of midline anterior skull base meningiomas remains to be defined. Open transcranial surgery is usually the first treatment option for large meningiomas, while less invasive techniques such as endoscopic surgery or radiosurgery might represent an alternative to open microsurgery for smaller lesions. The aim of our study is to investigate the outcome of open transcranial microsurgery in the resection of small (<35 mm) meningiomas of the midline anterior cranial base.
Clinical and surgical data from 43 patients affected by small midline anterior skull base meningiomas operated via an open transcranial approach were retrospectively reviewed.
The tumor diameter on its major axis ranged from 12 to 35 mm, with a mean diameter of 28 mm. Gross total resection (Simpson grades I-II) was achieved in 100% of cases through a pterional approach. Postoperative overall morbidity was 9%. It was 3% among patients <70 years. No mortality was reported. Postoperative visual outcome was significantly associated with preoperative visual performance (P = 0.02), but not with preoperative optic nerve compression as detected by magnetic resonance imaging (P = 0.116). Age >70 years was associated with postoperative visual impairment, although not significantly (P = 0.06). Visual function was preserved or improved in 95% of cases, in 100% of patients <70 years, and in 71% of patients with preoperative visual impairment.
In our experience, open transcranial surgery proved safe and effective for midline anterior skull base meningiomas smaller than 35 mm in all patients <70 years and in patients >70 years without preoperative visual deficit. Our data are consistent with the literature. Conversely, the standard of treatment for the subgroup of patients >70 years with preoperative visual deficit has not yet been defined. This specific subgroup of patients offers a topic for further investigation.
尽管外科技术不断进步,但中线前颅底脑膜瘤的最终治疗方案仍有待确定。开颅手术通常是大型脑膜瘤的首选治疗方法,而诸如内镜手术或放射外科等侵入性较小的技术可能是较小病变的开颅显微手术替代方案。我们研究的目的是探讨开颅显微手术切除中线前颅底小型(<35mm)脑膜瘤的疗效。
回顾性分析43例经开颅手术治疗的中线前颅底小型脑膜瘤患者的临床和手术资料。
肿瘤长径范围为12至35mm,平均直径为28mm。通过翼点入路,100%的病例实现了肿瘤全切(辛普森分级I-II级)。术后总体发病率为9%。70岁以下患者的发病率为3%。无死亡病例报告。术后视力结果与术前视力表现显著相关(P = 0.02),但与磁共振成像检测到的术前视神经受压情况无关(P = 0.116)。70岁以上患者与术后视力损害相关,尽管差异无统计学意义(P = 0.06)。95%的病例视力功能得以保留或改善,70岁以下患者中这一比例为100%,术前有视力损害的患者中这一比例为71%。
根据我们的经验,对于所有70岁以下以及70岁以上且术前无视力缺陷的患者,开颅手术治疗中线前颅底小于35mm的脑膜瘤是安全有效的。我们的数据与文献一致。相反,70岁以上且术前有视力缺陷这一亚组患者的治疗标准尚未确定。这一特定亚组患者为进一步研究提供了课题。